Gerald T Proehl Dermata Therapeutics, Inc. (DRMA) insider trading activity

DRMA Quotes by TradingView

Gerald T Proehl is President, CEO and Chairman of Dermata Therapeutics, Inc.. Currently has a direct ownership of 59,512 shares of DRMA, which is worth approximately $66,653. The most recent transaction as insider was on Nov 23, 2021, when has been sold 20,000 shares (Common Stock) at a price of $2.4 per share, resulting in proceeds of $48,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 59.5K
0% 3M change
0% 12M change
Total Value Held $66,653

GERALD T PROEHL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 23 2021
BUY
Open market or private purchase
$48,000 $2.4 p/Share
20,000 Added 25.15%
59,512 Common Stock

Also insider at

TENX
TENAX THERAPEUTICS, INC. Healthcare
GTP

Gerald T Proehl

President, CEO and Chairman
Morrisville, NC

Track Institutional and Insider Activities on DRMA

Follow Dermata Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DRMA shares.

Notify only if

Insider Trading

Get notified when an Dermata Therapeutics, Inc. insider buys or sells DRMA shares.

Notify only if

News

Receive news related to Dermata Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DRMA